Earnings History Data for Vanda Pharmaceuticals Inc. (VNDA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-11-2024	AH		VNDA	Vanda Pharmaceuticals Inc.	282.71	-0.09	-0.17	0.00	Vanda Pharmaceuticals GAAP EPS of -$0.09 beats by $0.07, revenue of $47.7M misses by $1.45M [11/6/2024 4:06 PM]	5.02	0.13 (2.64%)	4.79	-0.10 (-2.04%)	3.30 - 6.75	1,024,784	500,000	2,655
Vanda Pharmaceuticals GAAP EPS of -$0.09 beats by $0.07, revenue of $47.7M misses by $1.45M [11/6/2024 4:06 PM] Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results [2024-11-06 04:02PM] Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ... [2024-11-07 02:21AM] Vanda: Q3 Earnings Snapshot [Nov-06-24 04:12PM]
31-07-2024	AH		VNDA	Vanda Pharmaceuticals Inc.	349.19	-0.08	0.00	0.03	Vanda Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $50.5M beats by $2.64M [7/31/2024 4:49 PM]	5.63	-0.21 (-3.51%)	5.93	0.09 (1.54%)	3.30 - 6.75	914,098	590,000	10,342
Vanda Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $50.5M beats by $2.64M [7/31/2024 4:49 PM]
08-05-2024	AH		VNDA	Vanda Pharmaceuticals Inc.	278.48	-0.07	0.05	0.06	Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M [5/8/2024 4:03 PM]	5.01	-0.35 (-6.53%)	5.07	-0.29 (-5.41%)	3.30 - 6.92	1,803,609	1,460,000	40,339
Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M [5/8/2024 4:03 PM]
07-02-2024	AH		VNDA	Vanda Pharmaceuticals Inc.	199.64	-0.04	-0.09	0.12	Vanda Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $45.27M beats by $8.27M [2/7/2024 4:14 PM]	4.07	0.43 (11.68%)	3.70	0.06 (1.65%)	3.30 - 8.15	2,473,246	870,000	5,213
Vanda Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $45.27M beats by $8.27M [2/7/2024 4:14 PM]
27-07-2023	AH		VNDA	Vanda Pharmaceuticals Inc.	369.37	0.03	-0.13	0.05	Vanda Pharmaceuticals GAAP EPS of $0.03, revenue of $46.06M [7/27/2023 4:03 PM]	5.93	-0.53 (-8.13%)	6.46	0.0 (0.00%)	5.75 - 11.30	841,979	480,000	27,527
Vanda Pharmaceuticals GAAP EPS of $0.03, revenue of $46.06M [7/27/2023 4:03 PM]
03-05-2023	AH	4:00 PM ET (May 3)	VNDA	Vanda Pharmaceuticals Inc.	369.36	0.06	0.00	-0.11	Vanda Pharmaceuticals reports Q1 results [5/3/2023 4:46 PM]	6.87	0.48 (7.43%)	6.39	0.0 (0.00%)	5.75 - 11.90	553,809	520,000	45,765
Vanda Pharmaceuticals reports Q1 results [5/3/2023 4:46 PM]
08-02-2023	AH	4:00 PM ET (Feb 8)	VNDA	Vanda Pharmaceuticals Inc.	432.91	0.12	0.08	0.12	Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M [2/8/2023 4:04 PM]	7.23	0.08 (1.12%)	7.15	0.0 (0.00%)	6.73 - 14.15	588,199	510,000	30,407
Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M [2/8/2023 4:04 PM]
02-11-2022	AH	4:00 PM ET (Nov 2)	VNDA	Vanda Pharmaceuticals Inc.	592.20	0.06	0.10	0.14	Vanda Pharmaceuticals GAAP EPS of $0.06, revenue of $65.32M [11/2/2022 4:50 PM]	10.16	-0.15 (-1.45%)	10.31	0.0 (0.00%)	9.24 - 21.44	254,549	400,000	11,991
Vanda Pharmaceuticals GAAP EPS of $0.06, revenue of $65.32M [11/2/2022 4:50 PM] Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results [Nov-02-22 04:01PM] Vanda Pharmaceuticals (VNDA) Lags Q3 Earnings and Revenue Estimates [Nov-02-22 05:25PM]
03-08-2022	AH	4:10 PM ET (Aug 3)	VNDA	Vanda Pharmaceuticals Inc.	619.69	0.05	0.11	0.17	Vanda Pharmaceuticals GAAP EPS of $0.05, revenue of $64.39M [8/3/2022 4:03 PM]	10.27	-0.53 (-4.91%)	10.80	0.0 (0.00%)	9.24 - 21.44	269,061	310,000	22,288
Vanda Pharmaceuticals GAAP EPS of $0.05, revenue of $64.39M [8/3/2022 4:03 PM]
05-05-2022	AH	4:00 PM ET (May 5)	VNDA	Vanda Pharmaceuticals Inc.	577.32	-0.11	-0.01	0.15	Vanda Pharmaceuticals GAAP EPS of -$0.11 misses by $0.10, revenue of $60.19M beats by $2.19M [5/5/2022 4:26 PM]	9.60	-0.20 (-2.04%)	9.60	0.0 (0.00%)	9.24 - 21.86	532,441	550,000	27,492
Vanda Pharmaceuticals GAAP EPS of -$0.11 misses by $0.10, revenue of $60.19M beats by $2.19M [5/5/2022 4:26 PM] Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare Conference [May-04-22 04:30PM] Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results [May-05-22 04:10PM] Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 07:15PM]
23-02-2022	AH	4:00 PM ET (Feb 23)	VNDA	Vanda Pharmaceuticals Inc.	747.10	0.12	0.09	0.15	Vanda Pharmaceuticals GAAP EPS of $0.12, revenue of $68.01M [2/23/2022 4:04 PM]	13.78	0.58 (0.00%)	11.69	-1.38 (-10.56%)	11.20 - 21.86	758,447	517,545	24,920
Vanda Pharmaceuticals GAAP EPS of $0.12, revenue of $68.01M [2/23/2022 4:04 PM] Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-23-22 04:01PM]
03-11-2021	AH	4:00 PM ET (Nov 3)	VNDA	Vanda Pharmaceuticals Inc.	1,070	0.14	0.20	0.11	Vanda Pharmaceuticals EPS misses by $0.04, misses on revenue [11/3/2021 4:13 PM]	18.17	-2.97 (-14.05%)	18.13	-0.04 (-0.22%)	11.41 - 21.86	1,111,898	650,000	1,802
Vanda Pharmaceuticals EPS misses by $0.04, misses on revenue [11/3/2021 4:13 PM] Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results [Nov-03-21 04:01PM] Vanda Pharmaceuticals (VNDA) Misses Q3 Earnings and Revenue Estimates [Nov-03-21 06:05PM] Vanda Pharmaceuticals Inc (VNDA) Q3 2021 Earnings Call Transcript [Nov-03-21 10:01PM]
28-07-2021	AH	4:00 PM ET (Jul 28)	VNDA	Vanda Pharmaceuticals Inc.	1,090	0.17	0.17	0.16	Vanda Pharmaceuticals EPS beats by $0.03, misses on revenue [7/28/2021 4:07 PM]	17.89	-1.64 (-8.40%)	19.53	0.0 (0.00%)	9.00 - 21.86	444,771	300,000	10,969
Vanda Pharmaceuticals EPS beats by $0.03, misses on revenue [7/28/2021 4:07 PM] Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results [Jul-28-21 04:01PM] Vanda Pharmaceuticals Inc (VNDA) Q2 2021 Earnings Call Transcript [Jul-29-21 12:32AM] Vanda Pharmaceuticals (VNDA) Matches Q2 Earnings Estimates [Jul-28-21 08:25PM]
05-05-2021	AH	4:00 PM ET (May 5)	VNDA	Vanda Pharmaceuticals Inc.	922.33	0.15	0.14	0.01	Vanda Pharmaceuticals EPS beats by $0.01 [5/5/2021 4:06 PM]	17.51	0.93 (5.61%)	17.51	0.0 (0.00%)	9.00 - 20.51	496,331	290,000	5,158
NOTICE For Investors In NASDAQ: VNDA Shareholder Notice: Update in Lawsuit Against Vanda Pharmaceuticals Inc. Announced by Shareholders Foundation [May-04-21 07:30AM] Vanda Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 02:45PM] Vanda Pharmaceuticals Reports First Quarter 2021 Financial Results [May-05-21 04:01PM] Vanda Pharmaceuticals (VNDA) Surpasses Q1 Earnings and Revenue Estimates [May-05-21 06:15PM] Vanda Pharmaceuticals Inc (VNDA) Q1 2021 Earnings Call Transcript [May-05-21 09:30PM]
10-02-2021	AH	4:00 PM ET (Feb 10)	VNDA	Vanda Pharmaceuticals Inc.	829.13	0.15	0.10	0.08	Vanda Pharmaceuticals EPS beats by $0.01, beats on revenue [2/10/2021 4:08 PM]	18.61	3.20 (20.77%)	16.29	0.88 (5.71%)	7.12 - 19.42	3,930,544	406,140	2,235
Vanda Pharmaceuticals EPS beats by $0.01, beats on revenue [2/10/2021 4:08 PM] The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs [Feb-10-21 07:34AM]
28-10-2020	AH	4:00 PM ET (Oct 28)	VNDA	Vanda Pharmaceuticals Inc.	570.01	0.11	0.08	1.84	Vanda Pharmaceuticals EPS beats by $0.01, misses on revenue [10/28/2020 4:02 PM]	10.99	0.90 (8.97%)	10.81	0.72 (7.19%)	7.12 - 17.85	889,197	403,671	2,760

05-08-2020	AH	4:00 PM ET (Aug 5)	VNDA	Vanda Pharmaceuticals Inc.	549.87	0.16	0.08	0.21	Vanda Pharmaceuticals EPS beats by $0.12, beats on revenue [8/5/2020 4:06 PM]	11.40	0.38 (3.45%)	11.02	0.0 (0.00%)	7.12 - 17.85	299,854	551,550	442,124

06-05-2020	AH		VNDA	Vanda Pharmaceuticals Inc.	630.30	0.01	0.01	-0.01		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0